Search Results 581-590 of 19165 for creatinine

1. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

   Creatinine clearance or radioisotope glomerular filtration rate ≥ 70 mL/min OR serum creatinine normal based on age/gender as follows: ≤ 0.4 mg/dL (for ...

2. A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Platelet count ≥ 75 x 10^9/L. Serum creatinine ≥ ULN; or estimated creatinine clearance ≥ 50 mL/min by Cockroft-Gault method or other institutional ...

3. Nivolumab And Brentuximab Vedotin In Treating Older Patients With Untreated Hodgkin Lymphoma - Mayo Clinic

   ... creatinine clearance ≥ 30 and < 60 mL/min, or refused standard chemotherapy ... Alanine transaminase (ALT) ≤ 2.5 x ULN, obtained ≤ 7 days prior to registration ...

4. Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies - Mayo Clinic

   ... creatinine > ULN;; Chronic plasma therapy-responsive aHUS subjects (plasma therapy-sensitive) must require at least once-per-week plasma therapy for four ...

5. Chronic kidney disease - Doctors and departments - Mayo Clinic

   Creatinine test · Deceased-donor kidney transplant · Hemodialysis · Kidney biopsy · Kidney transplant · Living-donor kidney transplant · Minimally invasive ...

6. Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids - Mayo Clinic

   Serum creatinine ≥ 1.4. Pregnant or breast-feeding. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

7. Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Creatinine ≤ 1.5 x ULN; Creatinine clearance as calculated by the method of Cockroft and Gault ≥ 30 mL/minute; Patients with relapsed or refractory multiple ...

8. Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma - Mayo Clinic

   Serum creatinine ≤ 2.0 × upper limit of normal or calculated creatinine clearance: (CCr) ≥ 30 mL/min (≥ 0.5 mL/sec) using the Cockcroft-Gault equation ...

9. Phase I Study of LB-100 With Docetaxel in Solid Tumors - Mayo Clinic

   Patients must have adequate renal function, defined as serum creatinine ≤ 1.2 mg/dL (if > 1.2 mg/dL, a calculated creatinine clearance [Cockcroft-Gault method] ...

10. Molecular Regulation of Muscle Glucose Metabolism - Mayo Clinic

    Participation eligibility · Hematocrit ≥ 35 vol% · Serum creatinine ≤ 1.6 mg/dl · AST (SGOT) < 2 times upper limit of normal · ALT (SGPT) < 2 times upper limit of ...